Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment

Recombination within natural populations of pathogenic bacteria: Short-term empirical estimates and long-term phylogenetic consequences

Edward J. Feil, Edward C. Holmes, Debra E. Bessen et al. · Proceedings of the National Academy of Sciences · 2001 · 520 citations

Maximum Likelihood Trees, Antimicrobial Resistance Gene, Molecular Ecology +15

Immunogenicity of 2 Serogroup B Outer-Membrane Protein Meningococcal Vaccines

Jordan W. Tappero, A. Maldonado Ballesteros, D Williams et al. · JAMA · 1999 · 371 citations

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

John Donnelly, Duccio Medini, Giuseppe Boccadifuoco et al. · Proceedings of the National Academy of Sciences · 2010 · 296 citations · Full text

Unique Multicomponent Vaccine, Immunology, Immunodominance +21

Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization Schedules

Nicoletta Gossger, Matthew D. Snape, Ly‐Mee Yu et al. · JAMA · 2012 · 277 citations

Immunology, Vaccine Hesitancy, Effective Vaccine +19

Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study

Marı́a Elena Santolaya, Miguel L. O’Ryan, María Teresa Valenzuela et al. · The Lancet · 2012 · 262 citations

Vaccination, Vaccine Safety, Healthy Adolescents +9